| Primary |
| Blood Cholesterol Abnormal |
50.0% |
| Blood Cholesterol Increased |
50.0% |
|
| Atrial Fibrillation |
33.3% |
| Fall |
33.3% |
| Neuropathy Peripheral |
33.3% |
|
| Secondary |
| Product Used For Unknown Indication |
34.2% |
| Pain |
9.0% |
| Blood Cholesterol Increased |
7.2% |
| Drug Use For Unknown Indication |
4.9% |
| Depression |
3.7% |
| Thyroid Disorder |
3.7% |
| Gastrooesophageal Reflux Disease |
3.4% |
| Constipation |
3.1% |
| Diabetes Mellitus |
3.1% |
| Cardiac Disorder |
2.8% |
| Fibromyalgia |
2.8% |
| Hypertension |
2.8% |
| Myalgia |
2.8% |
| Nasal Septum Deviation |
2.8% |
| Restless Legs Syndrome |
2.8% |
| Blood Pressure Increased |
2.5% |
| Prophylaxis |
2.3% |
| Sleep Apnoea Syndrome |
2.3% |
| Atrial Fibrillation |
2.0% |
| Mood Swings |
2.0% |
|
| Fibromyalgia |
23.7% |
| Mental Disorder |
10.5% |
| Drug Hypersensitivity |
7.9% |
| Drug Ineffective |
5.3% |
| Dyspnoea |
5.3% |
| Pruritus |
5.3% |
| Nausea |
3.9% |
| Rectal Haemorrhage |
3.9% |
| Toxic Epidermal Necrolysis |
3.9% |
| Urinary Tract Infection |
3.9% |
| Accidental Exposure |
2.6% |
| Arrhythmia |
2.6% |
| Dizziness |
2.6% |
| Drug Screen Negative |
2.6% |
| Gastric Haemorrhage |
2.6% |
| Hypersensitivity |
2.6% |
| Pain In Extremity |
2.6% |
| Periorbital Haemorrhage |
2.6% |
| Pneumothorax |
2.6% |
| Stomach Discomfort |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
45.1% |
| Drug Use For Unknown Indication |
17.2% |
| Hypertension |
5.1% |
| Blood Cholesterol Increased |
3.8% |
| Rheumatoid Arthritis |
3.4% |
| Supplementation Therapy |
2.7% |
| Vitamin Supplementation |
2.5% |
| Pain |
2.3% |
| Prophylaxis |
1.8% |
| Diabetes Mellitus |
1.8% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Depression |
1.7% |
| Atrial Fibrillation |
1.7% |
| Crohn's Disease |
1.5% |
| Medical Diet |
1.3% |
| High Density Lipoprotein Decreased |
1.3% |
| Cardiac Disorder |
1.3% |
| Osteoporosis |
1.3% |
| Anxiety |
1.3% |
| Blood Triglycerides Increased |
1.2% |
|
| Flushing |
16.7% |
| Pruritus |
9.2% |
| Vomiting |
7.1% |
| Weight Decreased |
6.4% |
| Drug Ineffective |
5.7% |
| Paraesthesia |
5.2% |
| Weight Increased |
5.2% |
| Nausea |
5.0% |
| Pain In Extremity |
4.5% |
| Rash |
4.4% |
| Pain |
4.4% |
| Headache |
3.7% |
| Injection Site Pain |
3.5% |
| Skin Burning Sensation |
3.2% |
| Vision Blurred |
3.0% |
| Myalgia |
2.7% |
| Urinary Tract Infection |
2.5% |
| Urticaria |
2.5% |
| Fatigue |
2.5% |
| Diarrhoea |
2.4% |
|
| Interacting |
| Product Used For Unknown Indication |
30.9% |
| Type 2 Diabetes Mellitus |
8.6% |
| Blood Cholesterol Increased |
4.9% |
| Drug Use For Unknown Indication |
4.9% |
| Hypertension |
4.9% |
| Arthritis |
3.7% |
| Atrial Fibrillation |
3.7% |
| Blood Cholesterol Abnormal |
3.7% |
| Pain |
3.7% |
| Thyroid Disorder |
3.7% |
| Vitamin D Deficiency |
3.7% |
| Vitamin Supplementation |
3.7% |
| Anorectal Discomfort |
2.5% |
| Blood Cholesterol |
2.5% |
| Convulsion |
2.5% |
| Discomfort |
2.5% |
| Gastric Disorder |
2.5% |
| Hypertonic Bladder |
2.5% |
| Pruritus Genital |
2.5% |
| Pulmonary Embolism |
2.5% |
|
| Drug Interaction |
12.0% |
| Tremor |
12.0% |
| Gastric Disorder |
8.0% |
| International Normalised Ratio Abnormal |
8.0% |
| Vitamin D Deficiency |
8.0% |
| Drug Effect Decreased |
4.0% |
| Drug Ineffective |
4.0% |
| Feeling Abnormal |
4.0% |
| Gastrointestinal Haemorrhage |
4.0% |
| Haematoma |
4.0% |
| Haemolytic Anaemia |
4.0% |
| Heart Rate Increased |
4.0% |
| Hepatitis Acute |
4.0% |
| Muscle Spasms |
4.0% |
| Pneumonia |
4.0% |
| Pollakiuria |
4.0% |
| Rash Erythematous |
4.0% |
| Vision Blurred |
4.0% |
|
